Your browser doesn't support javascript.
loading
miR-542 inhibits tumorigenesis and chemoresistance through the AKT/NFκB pathway in cervical cancer.
Liu, Q H; Li, H L; Zhang, H; Li, Z; Zhao, M; Zhang, T T.
Afiliação
  • Liu QH; Department of clinical laboratory, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
  • Li HL; Department of clinical laboratory, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
  • Zhang H; Department of clinical laboratory, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
  • Li Z; Department of clinical laboratory, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
  • Zhao M; Department of clinical laboratory, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
  • Zhang TT; Department of clinical laboratory, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
J Biol Regul Homeost Agents ; 34(5): 1809-1817, 2020.
Article em En | MEDLINE | ID: mdl-33153258

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / MicroRNAs Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / MicroRNAs Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article